Publications by authors named "J Lubsen"

Article Synopsis
  • Longitudinal studies are crucial for understanding how various social and institutional factors influence health disparities related to COVID-19, especially regarding participant attrition in research due to unequal impacts of the pandemic.
  • The SHOW COVID-19 study surveyed adults from the Wisconsin cohort using online and phone interviews at different times, focusing on social and health-related experiences during the pandemic.
  • Results showed that participants differed significantly based on their survey mode, with online respondents being generally more educated and white, while phone respondents were more diverse and faced various health insecurities, highlighting the importance of diverse research methods for accurate representation.
View Article and Find Full Text PDF

A diagnosis was arrived at by doing something that the patient's other doctors hadn't: perform a biopsy.

View Article and Find Full Text PDF

To increase the acceptability of exoskeletons, there is growing attention toward finding an alternative soft actuator that can safely perform at close vicinity of the human body. In this study, we investigated the capability of the dielectric elastomer actuators (DEAs), for muscle-like actuation of rehabilitation robots. First, an artificial skeletal muscle was configured using commercially available stacked DEAs arranged in a 3x4 array of three parallel fibers consisting of four DEAs connected in series.

View Article and Find Full Text PDF

In this paper, we describe our efforts to integrate the Diabetes Prevention Program and the Bright Bodies program into a coordinated intensive lifestyle intervention program for families living in Fair Haven, an underserved Hispanic neighborhood in New Haven, Connecticut with high rates of obesity and prediabetes in adults and children.

View Article and Find Full Text PDF

We assessed the independent effects of beta blockers, calcium antagonists, lipid-lowering drugs, angiotensin converting enzyme inhibitors (ACEIs), angiotensin receptor blockers (ARBs), anti-platelet drugs, vitamin K antagonists, percutaneous coronary intervention (PCI) and coronary artery by-pass grafting (CABG) on mortality and on the composite endpoint of death, myocardial infarction, stroke or heart failure in patients with stable angina pectoris. We estimated the effects of the interventions used at baseline by multivariate Cox regression and during follow-up by G-estimation in 7,665 patients followed for a mean of 5 years in the ACTION trial. Adjusted hazard ratios (95% confidence intervals) comparing all cause mortality among users during follow-up to non-users were 1.

View Article and Find Full Text PDF